news
Is machine learning the answer for long-acting injectable drugs?
A study from the University of Toronto is one of the first to apply machine learning to the design of polymeric long-acting injectable drug formulations.
List view / Grid view
University of Toronto
news
Peginterferon-lambda accelerates COVID-19 recovery, finds trial
Peginterferon-lambda rapidly reduced non-hospitalised COVID-19 patients’ viral loads and expedited their recovery in a Phase II study.
news
IFN-α2b therapy shows promise in patients as potential COVID-19 treatment
A group of researchers has found that IFN-α2b therapy reduced blood levels of IL-6 and C-reactive protein, two inflammatory proteins found in COVID-19 patients.
news
More than 40 percent of women with asthma may develop COPD
"Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women," said Prof To...
news
Ozempic approved for the treatment of type 2 diabetes
Health Canada has approved Ozempic to improve glycemic control in adults with type 2 diabetes mellitus when metformin is not tolerated or contraindicated...
news
Steroid inhalers increase the risk of hard-to-treat infections
Older people who use steroid inhalers are more likely to suffer particular bacterial infections...
news
Injectable tissue patch may help repair damaged organs
Researchers have developed a technique that lets them use a small needle to inject a repair patch, without the need to open the chest cavity...
